1. Barak, Y., Juven, T., Haffner, R. & Oren, M. (1993) mdm2 expression is induced by wild type p53 activity. EMBO J 12: 461–468.
2. Bosari, S. & Viale, G. (1995) The clinical significance of p53 aberrations in human tumors. Virchows Arch 427: 229–241.
3. Bosari, S., Viale, G., Roncalli, M., Graziani, D., Borsani, G., Lee, A. K. & Coggi, G. (1995) p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol 147: 790–798.
4. Charpin, C., Devictor, B., Andrac, L., Amabile, J., Bergeret, D., Allasia, C. & Piana L and LaVaut, M. N. (1995) p53 quantitative immunocytochemical analysis in breast carcinomas. Hum Pathol 26: 159–166.
5. Chu, J., Tamimi, H., Ek, M. & Figge, D. (1982) Stage I vulvar cancer: criteria for microinvasion. Obstet Gynecol 59: 716–719.